✦ LIBER ✦

Reply: Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

✍ Scribed by Kollmannsberger, C; Bokemeyer, C

Book ID: 109997704
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 55 KB
Volume: 89
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6601177

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan in patients with relapsed or

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

✍ Kollmannsberger, C; Rick, O; Klaproth, H; Kubin, T; Sayer, H G; Hentrich, M; Wel 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 76 KB

Phase II study of biweekly administratio

Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer

✍ Takashi Hirose; Takao Shirai; Hiroo Ishida; Kohichi Ando; Tomohide Sugiyama; Soj 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 312 KB

Phase 2 study of irinotecan and paclitax

Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer

✍ Suresh S. Ramalingam; Judy Foster; William Gooding; Terry Evans; Matthew Sulecki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

Phase II trial of edatrexate in relapsed

Phase II trial of edatrexate in relapsed or refractory germ cell tumors: A Southwest Oncology Group study (SWOG 9124)

✍ Frederick J. Meyers; Danika Lew; Primo N. Lara; Steve Williamson; Ernest Marshal 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 48 KB

Bioavailability and phase II study of or

Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer

✍ Neal J. Meropol; Daryl S. Sonnichsen; Martin J. Birkhofer; Irene Ferreira; Diane 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 30 KB

Bioavailability and phase II study of or

Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer

✍ Neal J. Meropol; Daryl S. Sonnichsen; Martin J. Birkhofer; Irene Ferreira; Diane 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 122 KB